Learn More
Medchemexpress LLC Copanlisib | 1032568-63-0 | 480.52 | 100 MG

Supplier: Medchemexpress LLC 100MGHY15346
Copanlisib is a potent, selective, and ATP-competitive pan-class I PI3K inhibitor. It demonstrates over 2,000-fold selectivity against other lipid and protein kinases, with the exception of mTOR, and exhibits superior antitumor activity, making it suitable for cancer research.
- Potent, selective, and ATP-competitive pan-class I PI3K inhibitor
- Has IC₅₀s of 0.5 nM for PI3Kα, 0.7 nM for PI3Kδ, 3.7 nM for PI3Kβ, and 6.4 nM for PI3Kγ
- Exhibits over 2,000-fold selectivity against other lipid and protein kinases (excluding mTOR)
- Demonstrates superior antitumor activity
- Induces apoptosis in a subset of tumor cell lines
- Completely inhibits PI3K-mediated AKT phosphorylation
- Potently inhibits cell proliferation in various human tumor cell lines
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.